Stocks
Immunome (IMNM) EV/EBITDA US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| EV/EBITDA | ? | 0.20 | -3.45 | -4.20 | -0.19 | -2.68 | 0.73 | |
| Changes by years, y/y, % | +243% | -1 793% | +22% | -96% | +1 337% | |||
Immunome. EV/EBITDA
Immunome. EV/EBITDA, changes, %
Immunome (IMNM) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | -0.52 | -3.48 | 1.22 | -6.09 | -5.36 | 0.73 | |
| Changes by years, y/y, % | -29% | +1 783% | -315% | +171% | +921% | |||
| Changes by quarters, q/q, % | -77% | +562% | -135% | -600% | -12% | |||
